➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Harvard Business School
Moodys
Mallinckrodt
Boehringer Ingelheim

Last Updated: September 18, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LUCEMYRA

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Lucemyra

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03718065 Lofexidine's Impact on Stress and Opiate Use Not yet recruiting Medical University of South Carolina Phase 2 2019-01-02 Individuals with opioid use disorder who are stabilized on buprenorphine will be randomly assigned to receive placebo or lofexidine for 5 weeks. At the end of five weeks, they will complete a human laboratory stress task. Throughout the study a CREMA app (Cue Reactivity Ecological Momentary Assessment) will be used to monitor stress, craving and use in the natural environment.
NCT04056182 Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment Recruiting US WorldMeds LLC Phase 2 2019-09-01 This is an open-label pilot trial to evaluate the safety and tolerability of lofexidine in the management of opioid withdrawal symptoms while initiating outpatient treatment with naltrexone. The initiation procedure will be a flexible detoxification lasting 2 to 10 days concluding with the injection of XR-Naltrexone (Vivitrol). Vivitrol is a long-acting injection that contains enough medicine to last for one month blocking the effects of opioids.
NCT04056182 Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment Recruiting Frances R Levin Phase 2 2019-09-01 This is an open-label pilot trial to evaluate the safety and tolerability of lofexidine in the management of opioid withdrawal symptoms while initiating outpatient treatment with naltrexone. The initiation procedure will be a flexible detoxification lasting 2 to 10 days concluding with the injection of XR-Naltrexone (Vivitrol). Vivitrol is a long-acting injection that contains enough medicine to last for one month blocking the effects of opioids.
NCT04070157 Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal Recruiting US WorldMeds LLC Phase 2 2019-08-02 Stopping prescription opioid pain medications can be difficult due to withdrawal symptoms. This study will test if LUCEMYRA helps reduce withdrawal symptoms and helps more people reduce their opioid dose compared to placebo.
NCT04188730 A Relative Bioavailability Study Comparing Lofexidine Granules for Reconstitution to LUCEMYRA® (Lofexidine) Tablets Not yet recruiting National Institute on Drug Abuse (NIDA) Phase 1 2020-01-01 The purpose of this Phase 1, open-label, single-dose, randomized, two-treatment, two-period, two-sequence, crossover study is to assess the bioavailability of lofexidine granules for reconstitution to that of an equal dose of LUCEMYRA (lofexidine) tablets under fasted conditions in healthy, non-tobacco-, non-nicotine-using adult male and female participants.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Lucemyra

Condition Name

Condition Name for Lucemyra
Intervention Trials
Opioid-use Disorder 3
Opioid Withdrawal 1
Opioid Dependence 1
Opioid Addiction 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Lucemyra
Intervention Trials
Opioid-Related Disorders 2
Substance-Related Disorders 1
Stress Disorders, Traumatic 1
Stress Disorders, Post-Traumatic 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Lucemyra

Trials by Country

Trials by Country for Lucemyra
Location Trials
United States 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Lucemyra
Location Trials
Texas 1
North Carolina 1
Georgia 1
Florida 1
New York 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Lucemyra

Clinical Trial Phase

Clinical Trial Phase for Lucemyra
Clinical Trial Phase Trials
Phase 2/Phase 3 1
Phase 2 4
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Lucemyra
Clinical Trial Phase Trials
Not yet recruiting 4
Recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Lucemyra

Sponsor Name

Sponsor Name for Lucemyra
Sponsor Trials
US WorldMeds LLC 4
National Institute on Drug Abuse (NIDA) 2
Pharmacotherapies for Alcohol and Substance Abuse Consortium 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Lucemyra
Sponsor Trials
Other 5
Industry 4
U.S. Fed 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Colorcon
Merck
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.